Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by oceanblvdon Mar 04, 2015 10:34am
156 Views
Post# 23488102

gold mine

gold mineFradet is like an ameture gold miner that finds the mother load but has no idea how to get it out of the ground.  Under proper management this stock would be trading substaintially higher. The question is can Richard Borddeleau undo the damage Fradet has done to this company . If so we will have a substaintial winner. Fradet should be kept out of the day to day workings and suspend his salary until the company turns. Awarding options at this point to anyone has been a big mistake you dont reward failure.
<< Previous
Bullboard Posts
Next >>